Searched for
CDMO FACILITY INDIA
Shantha Biologics to Make Injectable Drug Cartridges for Novo NordiskShantha Biologics has secured a significant contract with Danish pharmaceutical giant Novo Nordisk to manufacture cartridges for injectable...- India's CDMO industry set for global shift as pharma diversifies beyond China: Sai Life SciencesIndian contract manufacturers are poised for significant growth as global pharmaceutical giants diversify away from China. Companies like S...
- Aurobindo Pharma enters biologics contract manufacturing with Rs 1,200-crore Telangana facilityAurobindo Pharma has launched TheraNym, a major biologics manufacturing plant in Telangana. This facility will produce biologic medicines f...
- Tata-backed MedTherapy claims CAR-T breakthrough with one-day productionTata Sons-backed biotech startup MedTherapy said it has developed a next-generation CAR-T cell therapy manufacturing platform that can redu...
- True North buys 25% stake in pharma co EmbioPrivate equity firm True North is investing approximately $50 million in Embio Ltd. Embio manufactures Active Pharmaceutical Ingredients fo...
- Deepa Jewellers, Cotec Healthcare receive Sebi approval for IPOsDeepa Jewellers, a B2B hallmarked gold jewellery processor based in Hyderabad, and Cotec Healthcare, a pharmaceutical CDMO, both received S...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Blue Jet Healthcare to invest Rs 2,300 crore in mega pharma facility in AndhraBlue Jet Healthcare is building a major pharmaceutical plant in Andhra Pradesh. The ₹2,300-crore facility will manufacture specialty chemic...
- Nandan Nilekani’s Fundamentum leads $15 million bet on materials science startup WhizzoWhizzo has raised $15 million in a round led by Nandan Nilekani’s Fundamentum, with participation from South Korea-based deeptech player LB...
- China’s India headache: The growing pharmaceutical industryIndian CDMOs are strategically expanding through acquisitions in the US and Europe, driven by global pharma's nearshoring trend and a desir...
- Granules India shares in focus on acquiring Swiss firm for Rs 192 crGranules India has acquired Swiss CDMO company Senn Chemicals AG for Rs 192 crore, expanding its peptide therapeutics market presence. The ...
- Akum Drugs shares tumble 5% despite posting Rs 60 crore Q1 profitAkum Drugs Share Price: Akum Drugs and Pharmaceuticals' shares dropped 5% to Rs 895 despite reporting a Rs 60 crore net profit for the June...
- Akums Pharma placed at a vantage point in pharma growthAkums Drugs &Pharma, a prominent contract development and manufacturing company in India, launched an ₹1,856-crore IPO with ₹680 crore in f...
- Maiva Pharma raises Rs 1000 crore from Morgan Stanley Private Equity, InvAscentMorgan Stanley PE Asia and India Life Sciences Fund are investing almost equally, total stake with both funds combined will be over 60% pos...
- Suven Pharma, Cohance Lifesciences to merge to bolster CDMO businessPromoter of Suven Pharma, Advent International, had said last year that it would merge the two businesses post the buyout of its significan...
- PI Industries stock zooms 13%, hits two-month high on pharma acquisitionsOn Thursday, PI Industries announced twin acquisitions into pharma API and CDMO space, stating that it is committed to building a different...
- Glenmark Life Sciences Q3 Results: Profit rises 1% on API strengthGlenmark Life Sciences, which was spun off from Glenmark Pharmaceuticals in 2019 to focus on the API business, posted revenue from operatio...
- Ajay Piramal explains pharma business demerger, growth prospects and more“Whatever we committed to the market we have delivered and probably a little more than that. We had committed that we will bring in equity ...
- Windlas Biotech lists at 5% discount to issue priceThe IPO by the Dehradun-based pharma formulations company ran from August 4 to August 6 and was sold in the Rs 448-460 range.
- Windlas Biotech offers its shares at 64x PE. Should you subscribe?The Dehradun-based firm will raise Rs 165 crore through issuance of fresh equity shares, while the promoters and existing shareholders will...
Load More
